Search Results - "Ji, Dengbo"

Refine Results
  1. 1

    Design and synthesis of doublecortin-like kinase 1 inhibitors and their bioactivity evaluation by Pan, Pengming, Ji, Dengbo, Li, Zhongjun, Meng, Xiangbao

    “…Doublecortin-like kinase 1 (DCLK) is a microtubule-associated serine/threonine kinase that is upregulated in a wide range of cancers and is believed to be…”
    Get full text
    Journal Article
  2. 2

    Combination of radiotherapy and suppression of Tregs enhances abscopal antitumor effect and inhibits metastasis in rectal cancer by Ji, Dengbo, Song, Can, Li, Yongheng, Xia, Jinhong, Wu, Yanjing, Jia, Jinying, Cui, Xinxin, Yu, Songmao, Gu, Jin

    Published in Journal for immunotherapy of cancer (01-10-2020)
    “…BackgroundDistant metastasis is the major cause of mortality in patients with locally advanced rectal cancer (LARC) following neoadjuvant chemoradiotherapy…”
    Get full text
    Journal Article
  3. 3

    MicroRNA-181a promotes tumor growth and liver metastasis in colorectal cancer by targeting the tumor suppressor WIF-1 by Ji, Dengbo, Chen, Zhiguo, Li, Ming, Zhan, Tiancheng, Yao, Yunfeng, Zhang, Zhiqian, Xi, Jianzhong, Yan, Li, Gu, Jin

    Published in Molecular cancer (23-04-2014)
    “…Given the emerging role of microRNA in tumor disease progression, we investigated the association between microRNA expression, liver metastasis and prognosis…”
    Get full text
    Journal Article
  4. 4

    Overexpression of LAMC2 predicts poor prognosis in colorectal cancer patients and promotes cancer cell proliferation, migration, and invasion by Huang, Dandan, Du, Changzheng, Ji, Dengbo, Xi, Jianzhong, Gu, Jin

    Published in Tumor biology (01-06-2017)
    “…Laminin γ2 (LAMC2) has been reported to be involved in the development and progression of a variety of tumors. However, its function in human colorectal cancer…”
    Get full text
    Journal Article
  5. 5

    Predictive value of proteomic markers for advanced rectal cancer with neoadjuvant chemoradiotherapy by Wang, Hanyang, Ji, Dengbo, Tian, Huifang, Gao, Zhaoya, Song, Can, Jia, Jinying, Cui, Xinxin, Zhong, Lijun, Shen, Jing, Gu, Jin

    Published in BMC cancer (09-08-2022)
    “…Abstract Background Preoperative neoadjuvant chemoradiation (nCRT) has been the standard treatment for locally advanced rectal cancer. Serum biomarkers to…”
    Get full text
    Journal Article
  6. 6

    FAP promotes metastasis and chemoresistance via regulating YAP1 and macrophages in mucinous colorectal adenocarcinoma by Ji, Dengbo, Jia, Jinying, Cui, Xinxin, Li, Zhaowei, Wu, Aiwen

    Published in iScience (16-06-2023)
    “…Mucinous colorectal adenocarcinoma (MC) is less likely to respond to chemotherapy and is associated with poorer prognosis compared with non-MC (NMC)…”
    Get full text
    Journal Article
  7. 7

    Enhancement of Sensitivity to Chemo/Radiation Therapy by Using miR-15b against DCLK1 in Colorectal Cancer by Ji, Dengbo, Zhan, Tiancheng, Li, Ming, Yao, Yunfeng, Jia, Jinying, Yi, Haizhao, Qiao, Meng, Xia, Jinhong, Zhang, Zhiqian, Ding, Huirong, Song, Can, Han, Yong, Gu, Jin

    Published in Stem cell reports (11-12-2018)
    “…Chemo-/radiotherapy resistance is the main cause accounting for most treatment failure in colorectal cancer (CRC). Tumor-initiating cells (TICs) are the…”
    Get full text
    Journal Article
  8. 8

    Glycan analysis of colorectal cancer samples reveals stage-dependent changes in CEA glycosylation patterns by Zhao, Qianqian, Zhan, Tiancheng, Deng, Zaian, Li, Qianqian, Liu, Yaming, Yang, Shaojie, Ji, Dengbo, Li, Yan

    Published in Clinical proteomics (02-03-2018)
    “…Carcinoembryonic antigen (CEA) is a glycoprotein associated with colorectal cancer (CRC). While the functions of its gene and protein have been fully…”
    Get full text
    Journal Article
  9. 9

    Prognostic role of serum AZGP1, PEDF and PRDX2 in colorectal cancer patients by Ji, Dengbo, Li, Ming, Zhan, Tiancheng, Yao, Yunfeng, Shen, Jing, Tian, Huifang, Zhang, Zhiqian, Gu, Jin

    Published in Carcinogenesis (New York) (01-06-2013)
    “…This study was designed to develop novel and better reliable serum prognostic biomarkers for colorectal cancer (CRC). A 50 sample set including CRC, adenoma…”
    Get full text
    Journal Article
  10. 10

    Hemolysin BL from novel Bacillus toyonensis BV-17 induces antitumor activity both in vitro and in vivo by Chen, Jiajia, Hu, Shoukui, Ji, Dengbo, Gao, Zhaoya, Wang, Hanyang, Yang, Yong, Chen, Yongkang, Gu, Jin

    Published in Gut microbes (09-11-2020)
    “…The gut microbiota plays an important role in cancer development and immunotherapy. Bacterial toxins have enormous antitumor potential due to their…”
    Get full text
    Journal Article
  11. 11

    Serum-based microRNA signature predicts relapse and therapeutic outcome of adjuvant chemotherapy in colorectal cancer patients by Ji, Dengbo, Qiao, Meng, Yao, Yunfeng, Li, Ming, Chen, Hailong, Dong, Qi, Jia, Jinying, Cui, Xinxin, Li, Zhaowei, Xia, Jinhong, Gu, Jin

    Published in EBioMedicine (01-09-2018)
    “…Approximately 60% of patients with colorectal cancer (CRC) undergo either local recurrence or distant metastases after surgery. Current prognostic biomarkers…”
    Get full text
    Journal Article
  12. 12

    Surgery may not benefit patients with locally advanced rectal cancer who achieved clinical complete response following neoadjuvant chemoradiotherapy by Han, Zihan, Li, Ming, Chen, Jiajia, Ji, Dengbo, Zhan, Tiancheng, Peng, Yifan, Xue, Weicheng, Li, Yongheng, Cai, Yong, Sun, Yingshi, Wu, Qi, Du, Changzheng, Gu, Jin

    Published in Asian journal of surgery (01-01-2022)
    “…We compared the long-term outcome of the watch and wait (WW) strategy and surgery in patients with locally advanced rectal cancer. This prospective cohort…”
    Get full text
    Journal Article
  13. 13

    The implications from the interplay of neoadjuvant chemoradiotherapy and the immune microenvironment in rectal cancer by Shi, Mengyuan, Chen, Yongkang, Ji, Dengbo

    Published in Future oncology (London, England) (01-09-2022)
    “…Neoadjuvant chemoradiotherapy (nCRT) is recommended for the treatment of locally advanced rectal cancer. Even though the combination of nCRT and immune…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Abstract 2430: HOXC6 promotes tumorigenesis of right-sided colon cancer by li, Xin, Xia, Jinhong, Ji, Dengbo, Gu, Jin

    Published in Cancer research (Chicago, Ill.) (01-07-2021)
    “…Abstract Colorectal cancer (CRC) is a common malignant tumor of the digestive tract, with high heterogeneity. The significant difference in prognosis and…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Tumor mutation burden in blood predicts benefit from neoadjuvant chemo/radiotherapy in locally advanced rectal cancer by Ji, Dengbo, Zhang, Dakui, Zhan, Tiancheng, Jia, Jinying, Han, Wenbo, Li, Zhaowei, Li, Ming, Song, Can, Wang, Jianfei, Gu, Jin

    Published in Genomics (San Diego, Calif.) (01-01-2021)
    “…Distant metastasis has been the major concern of prognosis in patients with locally advanced rectal cancer (LARC). The purpose of this study was to investigate…”
    Get full text
    Journal Article
  18. 18

    UVRAG Promotes Tumor Progression through Regulating SP1 in Colorectal Cancer by Shi, Mengyuan, An, Guo, Chen, Nan, Jia, Jinying, Cui, Xinxin, Zhan, Tiancheng, Ji, Dengbo

    Published in Cancers (27-04-2023)
    “…Colorectal cancer (CRC) is the third most common type of cancer. The ultraviolet radiation resistance-associated gene (UVRAG) plays a role in autophagy and has…”
    Get full text
    Journal Article
  19. 19

    Total Neoadjuvant Therapy With PD-1 Blockade for High-Risk Proficient Mismatch Repair Rectal Cancer by Li, Yingjie, Pan, Chaohu, Gao, Yuye, Zhang, Li, Ji, Dengbo, Cui, Xiaoli, Zhang, Xiaoyan, Cai, Yong, Zhang, Yangzi, Yao, Yunfeng, Wang, Lin, Leng, Jiahua, Zhan, Tiancheng, Wu, Dongfang, Gao, Zhibo, Sun, Ying-Shi, Li, Zhongwu, Luo, Haitao, Wu, Aiwen

    Published in JAMA surgery (01-05-2024)
    “…Total neoadjuvant therapy (TNT) is the standard treatment for locally advanced rectal cancer, especially for patients with high-risk factors. However, the…”
    Get more information
    Journal Article
  20. 20

    PKUCH 04 trial: Total neoadjuvant chemoradiation combined with neoadjuvant PD-1 blockade for pMMR/MSS locally advanced middle to low rectal cancer by WU, Aiwen, Li, Yingjie, Ji, Dengbo, Zhang, Li, Zhang, Xiaoyan, Cai, Yong, Zhang, Yangzi, Yao, Yunfeng, Wang, Lin, Leng, Jiahua, Zhan, Tiancheng, Sun, Ying-Shi, Li, Zhongwu

    Published in Journal of clinical oncology (01-06-2022)
    “…3609 Background: Total neoadjuvant therapy (TNT) with induction chemotherapy and chemoradiation is the standard of care for locally advanced rectal cancers…”
    Get full text
    Journal Article